CN1015361B - 对映体的戊二酰胺利尿剂 - Google Patents

对映体的戊二酰胺利尿剂

Info

Publication number
CN1015361B
CN1015361B CN89103437A CN89103437A CN1015361B CN 1015361 B CN1015361 B CN 1015361B CN 89103437 A CN89103437 A CN 89103437A CN 89103437 A CN89103437 A CN 89103437A CN 1015361 B CN1015361 B CN 1015361B
Authority
CN
China
Prior art keywords
ethyl
acid
benzyl
formula
catalytic hydrogenation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CN89103437A
Other languages
English (en)
Chinese (zh)
Other versions
CN1037704A (zh
Inventor
约翰·克里斯托弗·丹尼路维兹
迈克尔·特里维廉·威维斯
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of CN1037704A publication Critical patent/CN1037704A/zh
Publication of CN1015361B publication Critical patent/CN1015361B/zh
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/40—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/18—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Detergent Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Cosmetics (AREA)
CN89103437A 1988-05-19 1989-05-19 对映体的戊二酰胺利尿剂 Expired CN1015361B (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8811873.2 1988-05-19
GB888811873A GB8811873D0 (en) 1988-05-19 1988-05-19 Therapeutic agents

Publications (2)

Publication Number Publication Date
CN1037704A CN1037704A (zh) 1989-12-06
CN1015361B true CN1015361B (zh) 1992-02-05

Family

ID=10637176

Family Applications (1)

Application Number Title Priority Date Filing Date
CN89103437A Expired CN1015361B (zh) 1988-05-19 1989-05-19 对映体的戊二酰胺利尿剂

Country Status (29)

Country Link
EP (1) EP0342850B1 (enExample)
JP (1) JPH072699B2 (enExample)
KR (1) KR920000561B1 (enExample)
CN (1) CN1015361B (enExample)
AT (1) ATE76399T1 (enExample)
AU (1) AU602813B2 (enExample)
CA (1) CA1331197C (enExample)
CS (1) CS274502B2 (enExample)
DD (1) DD283772A5 (enExample)
DE (1) DE68901582D1 (enExample)
DK (1) DK172032B1 (enExample)
EG (1) EG19007A (enExample)
ES (1) ES2037418T3 (enExample)
FI (1) FI93541C (enExample)
GB (1) GB8811873D0 (enExample)
GR (1) GR3004968T3 (enExample)
HU (1) HU205067B (enExample)
IE (1) IE60724B1 (enExample)
IL (1) IL90267A (enExample)
MX (1) MX16067A (enExample)
MY (1) MY104735A (enExample)
NO (1) NO173647C (enExample)
NZ (1) NZ229186A (enExample)
PH (1) PH26740A (enExample)
PL (1) PL154813B1 (enExample)
PT (1) PT90584B (enExample)
SU (1) SU1766251A3 (enExample)
YU (1) YU47973B (enExample)
ZA (1) ZA893696B (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8812597D0 (en) * 1988-05-27 1988-06-29 Pfizer Ltd Therapeutic agents
GB8820844D0 (en) * 1988-09-05 1988-10-05 Pfizer Ltd Therapeutic agents
GB9000725D0 (en) * 1990-01-12 1990-03-14 Pfizer Ltd Therapeutic agents
ATE130292T1 (de) * 1993-09-22 1995-12-15 Pfizer Res & Dev Hydrierung.
US7468390B2 (en) 2002-01-17 2008-12-23 Novartis Ag Methods of treatment and pharmaceutical composition
AR057882A1 (es) 2005-11-09 2007-12-26 Novartis Ag Compuestos de accion doble de bloqueadores del receptor de angiotensina e inhibidores de endopeptidasa neutra
US8993631B2 (en) 2010-11-16 2015-03-31 Novartis Ag Method of treating contrast-induced nephropathy
RU2667643C2 (ru) 2012-08-24 2018-09-21 Новартис Аг Ингибиторы nep для лечения заболеваний, характеризующихся увеличением или ремоделированием предсердия
WO2017033128A1 (en) 2015-08-25 2017-03-02 Novartis Ag Biphenyl-substitued 4-amino-butyric acid derivatives and their use in the synthesis of nep inhibitors
US20180311241A1 (en) 2015-10-29 2018-11-01 Cadila Healthcare Limited Pharmaceutical synergistic combination

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR880007441A (ko) * 1986-12-11 1988-08-27 알렌 제이.스피겔 스피로-치환된 글루타르아미드 이뇨제

Also Published As

Publication number Publication date
DE68901582D1 (de) 1992-06-25
JPH0222256A (ja) 1990-01-25
CA1331197C (en) 1994-08-02
MX16067A (es) 1993-10-01
ZA893696B (en) 1990-12-28
GB8811873D0 (en) 1988-06-22
EG19007A (en) 1994-11-30
DD283772A5 (de) 1990-10-24
IE60724B1 (en) 1994-08-10
SU1766251A3 (ru) 1992-09-30
JPH072699B2 (ja) 1995-01-18
HUT53596A (en) 1990-11-28
PT90584B (pt) 1994-09-30
PL279491A1 (en) 1989-11-27
FI93541B (fi) 1995-01-13
KR920000561B1 (ko) 1992-01-16
NZ229186A (en) 1990-10-26
IL90267A (en) 1993-08-18
ATE76399T1 (de) 1992-06-15
HU205067B (en) 1992-03-30
AU602813B2 (en) 1990-10-25
IL90267A0 (en) 1989-12-15
MY104735A (en) 1994-05-31
CS274502B2 (en) 1991-04-11
PL154813B1 (en) 1991-09-30
FI93541C (fi) 1995-04-25
ES2037418T3 (es) 1993-06-16
AU3490489A (en) 1989-11-23
KR900017993A (ko) 1990-12-20
IE891613L (en) 1989-11-19
FI892386A0 (fi) 1989-05-18
NO892002L (no) 1989-11-20
NO892002D0 (no) 1989-05-18
PH26740A (en) 1992-09-28
NO173647B (no) 1993-10-04
EP0342850A1 (en) 1989-11-23
FI892386L (fi) 1989-11-20
DK172032B1 (da) 1997-09-22
GR3004968T3 (enExample) 1993-04-28
EP0342850B1 (en) 1992-05-20
CS296589A2 (en) 1990-09-12
DK240889D0 (da) 1989-05-18
CN1037704A (zh) 1989-12-06
DK240889A (da) 1989-11-20
PT90584A (pt) 1989-11-30
YU102289A (en) 1991-06-30
YU47973B (sh) 1996-08-13
NO173647C (no) 1994-01-12

Similar Documents

Publication Publication Date Title
US5770615A (en) Catecholamine surrogates useful as β3 agonists
CN1295200C (zh) 2－丁基－3－(4－[3－(二丁基氨基)丙氧基]苯甲酰基)－5－硝基苯并呋喃盐酸盐及其制备
CN1135209A (zh) 新的氨基甲酸苯基烷基氨基醇酯及其制备方法
CN1173863A (zh) 邻氨基甲酰基－(d)－苯基丙氨醇化合物及其制备方法
CN1252072C (zh) 4,6－二氨基嘧啶并[5,4－d]嘧啶的制备方法
CN1882535A (zh) 2－氧代－1－吡咯烷衍生物的制备方法
CN1038639A (zh) 旋光的萘并硫氮杂类的制备方法
KR920000561B1 (ko) 거울상 이성체 글루타르아미드 이뇨제
CN1266131C (zh) 制备杂环茚类似物的方法
CN1063487A (zh) 苯氧基烷基羧酸衍生物及其制备方法
CN1219756C (zh) 制备联苯化合物的方法
CN1014992B (zh) 喹唑啉二酮和吡啶并嘧啶二酮的制备方法
CN1491951A (zh) 吖庚因的中间体
CN1037179C (zh) 1,4－苯并噁嗪衍生物
CN1192017C (zh) 环己烷羧酸的制备方法
CN1171868C (zh) 含有氨基硫羰基的新颖的氨基甲酸酯化合物及其制备方法
CN1028361C (zh) 戊二酸衍生物的制备方法
CN1039998C (zh) 取代的环烷基乙酰胺及其制法、药物和用途
CN1244543C (zh) 制备4－(烷基)－3－烷氧基－苯胺型化合物的方法
CN1043703A (zh) 制备茚满衍生物的方法
JP2769058B2 (ja) シクロプロパン誘導体の製法
CN1243126A (zh) 制备手性内酯的方法
CN1649594A (zh) 贝那普利盐酸盐的制备方法
CN1071315C (zh) 新氨基甲酸酯类化合物及其制法
CN1515561A (zh) 生产手性琥珀酸衍生物的方法

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C13 Decision
GR02 Examined patent application
C14 Grant of patent or utility model
GR01 Patent grant
C15 Extension of patent right duration from 15 to 20 years for appl. with date before 31.12.1992 and still valid on 11.12.2001 (patent law change 1993)
OR01 Other related matters
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee